Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|October 1, 1996
ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotypeR Muñoz, A G De La CampaJournal of Bacteriology|April 1, 1996
Quinine specifically inhibits the proteolipid subunit of the F0F1 H+ -ATPase of Streptococcus pneumoniaeR Muñoz, E García, A G De la CampaJournal of Bacteriology|July 1, 1995
Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistanceR Muñoz, M Bustamante, A G de la CampaJournal of Bacteriology|June 6, 1998
Molecular characterization of the gene encoding the DNA gyrase A subunit of Streptococcus pneumoniaeD Balas, E Fernández-Moreira, A G De La CampaMolecular Microbiology|May 1, 1994
Molecular basis of the optochin-sensitive phenotype of pneumococcus: characterization of the genes encoding the F0 complex of the Streptococcus pneumoniae and Streptococcus oralis H(+)-ATPasesA Fenoll, R Muñoz, E García, et al.Journal of Molecular Biology|May 20, 1990
Initiation of replication of plasmid pLS1. The initiator protein RepB acts on two distant DNA regionsA G de la Campa, G H del Solar, M EspinosaMicrobial Drug Resistance (Larchmont, N.Y.)|July 1, 1997
Molecular bases of three characteristic phenotypes of pneumococcus: optochin-sensitivity, coumarin-sensitivity, and quinolone-resistanceA G de la Campa, E García, A Fenoll, et al.Antimicrobial Agents and Chemotherapy|March 18, 2000
Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniaeM J Ferrándiz, A Fenoll, J Liñares, et al.Molecular Microbiology|March 11, 2000
Regulation of competence for genetic transformation in Streptococcus pneumoniae: expression of dpnA, a late competence gene encoding a DNA methyltransferase of the DpnII restriction systemS A Lacks, S Ayalew, A G de la Campa, et al.Microbial Drug Resistance (Larchmont, N.Y.)|March 29, 2001
Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteinsE Fernandez-Moreira, D Balas, I Gonzalez, et al.Pageof 3